Financials
Financial year 2025
GENAPHAR from Brussel, company number BE0416169095, closed financial year 2025 with a result of € 18,373 after tax. For that financial year GENAPHAR recorded a gross margin of € 18,365 and equity of € 97,645. Compared with financial year 2024, the result moved from € 10,305 to € 18,373. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2026.
€ 97,645
▲ 23% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 18,373
▲ 78% vs 2024
Profit after tax over the fiscal year.
€ 78,052
▲ 18% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 35,645.
Debts at end 2025
€ 16,579
Loans from banks and other lenders, long and short.
€ 24,121
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,985
▲ 20% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 49,204 | € -23,376 | € 17,035 | € 18,365 | ▲ 8% |
| Profit after taxes | € 46,248 | € -26,773 | € 10,305 | € 18,373 | ▲ 78% |
| Equity | € 95,739 | € 68,967 | € 79,272 | € 97,645 | ▲ 23% |
| Total debts | € 20,625 | € 20,587 | € 50,841 | € 49,685 | ▼ 2% |
| Cash | € 21,257 | € 17,973 | € 65,869 | € 78,052 | ▲ 18% |
| Retained profit | € 33,739 | € 6,967 | € 17,272 | € 35,645 | ▲ 106% |
| Bank debt | € 16,579 | € 16,579 | € 16,579 | € 16,579 | |
| Balance sheet total | € 116,364 | € 89,554 | € 130,113 | € 147,330 | ▲ 13% |
By gross margin, GENAPHAR ranks 42nd of 50 companies with main activity “Detailhandel in farmaceutische producten” in Brussel that publish figures (fiscal year 2025).
Key figures of GENAPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about GENAPHAR the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to GENAPHAR?
What happened at GENAPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 18,373 (▲ 78% vs 2024). filed late Source: NBB ↗
- GERY VANDEWALLE stepped down as director. NBB
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
In short
From € 46,248 profit in 2022 to € 18,373 profit in 2025.
Paid € 3,248 in corporate taxes since 2022.
Best year ever: 2022, with € 46,248 profit.
Management
Behind GENAPHAR are BEGGA VANDEWALLE and ANNITA BOEL.
Directors
According to the 2025 annual accounts
BEGGA VANDEWALLE
Managing director
ANNITA BOEL
Director
GERY VANDEWALLE
Director
· until 2026
Establishments
Establishment units
Physical locations of this company
Arteveldestraat 20
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brussel
Same main activity (Detailhandel in farmaceutische producten), 57 active companies in Brussel, largest first.
VERTEX PHARMACEUTICALS (BELGIUM)
€ 88.9 million revenue · 2025
€ 2.1 million gross margin · 2025
€ 1.5 million gross margin · 2025
€ 771,406 gross margin · 2025
€ 685,436 gross margin · 2025
€ 596,330 gross margin · 2024
Details
- Company number
- 0416.169.095
- VAT number
- BE 0416.169.095
- Registered office
- Arteveldestraat 20, 1000 Brussel
- Names & denominations
- GENAPHAR
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 June 1976
- Peppol
- Active · Active since 8 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers